
46.35 BATS BZX Real-Time Price As of 10:26am ET | ![]() Today’s Change | 42.63 Today|||52-Week Range 57.82 | -4.29% Year-to-Date |
2 Biotech Stocks You Can Buy and Hold for the Next Decade 8:30am / MotleyFool.com - Paid Partner Content | Teva Pharmaceutical: Long-Term Cash Cow Nov 27 / GuruFocus News - Paid Partner Content |
Regeneron (REGN), Sanofi's Dupixent Succeeds in 2nd COPD Study Nov 27 / Zacks.com - Paid Partner Content | Regeneron (REGN) Stock Rallies 10% YTD: What Lies Ahead? Nov 24 / Zacks.com - Paid Partner Content |
Previous close | 46.60 |
Today’s open | 46.12 |
Day’s range | 46.00 - 46.35 |
Volume | 17,941 |
Average volume (3 months) | 1,826,545 |
Market cap | $117.1B |
Earnings growth (last year) | +19.66% |
Earnings growth (this year) | +0.91% |
Earnings growth (next 5 years) | +4.00% |
Revenue growth (last year) | +1.25% |
P/E ratio | 11.8 |
Price/Sales | 2.69 |
Price/Book | 1.46 |
Today’s change | Today’s % change | |
---|---|---|
BMYBristol-Myers Squibb | -0.10 | -0.21% |
VRTXVertex Pharmaceutica... | +2.18 | +0.62% |
REGNRegeneron Pharmaceut... | +11.81 | +1.46% |
ZTSZoetis Inc | -1.66 | -0.94% |
Next reporting date | February 1, 2024 |
EPS forecast (this quarter) | $0.95 |
Annual revenue (last year) | $45.2B |
Annual profit (last year) | $8.8B |
Net profit margin | 19.47% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Paris, Ile-de-france |